SCHEMBL31612976

SCHEMBL31612976

Nc1nn2c(c1Br)C(=O)CCC2

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.32
TSHR P16473 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31613039 0.70 IKBKB (0.32)
SCHEMBL1007963 0.68 LMNA (0.33) TSHR
SCHEMBL29777584 0.66 PLK1 (0.33)
SCHEMBL13424047 0.62 CYP1A2 (0.48)
SCHEMBL21612415 0.60 LMNA (0.31)
SCHEMBL22727355 0.58
SCHEMBL19044203 0.58 CYP11B1 (0.38)
SCHEMBL13424070 0.57 CYP1A2 (0.43)
SCHEMBL22738202 0.56 HTR2C (0.32)
SCHEMBL14177833 0.56 ALDH1A1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025119300-A1 MYT1 KINASE INHIBITOR COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 广东东阳光药业股份有限公司 2025-06-12 WO disclosed
CN-120118088-A Myt1 kinase inhibitor compounds, pharmaceutical compositions thereof and uses thereof 广东东阳光药业股份有限公司 2025-06-10 CN disclosed